Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation-Reference-Cited by-同舟云学术

Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation

Published:2019-02 Issue: Volume:296 Page:29-39
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Cao Enyuan,Lindgren Anna,Martinsson Sofia,Hu Luojuan,Lindfors Lennart,Sigfridsson Kalle,Skantze Urban,Michaëlsson Erik,Trevaskis Natalie L.,Porter Christopher J.H.^ORCID

Funder

National Health and Medical Research Council of Australia

Australian Research Council

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Ectopic lymphoid-like structures in infection, cancer and autoimmunity;Pitzalis;Nat. Rev. Immunol.,2014

2. Impaired lymphatic contraction associated with immunosuppression;Liao;Proc. Natl. Acad. Sci.,2011

3. Immunopathogenesis of acute AIDS virus infection;Picker;Curr. Opin. Immunol.,2006

4. Role of the lymphatics in cancer metastasis and chemotherapy applications;McAllaster;Adv. Drug Deliv. Rev.,2011

5. From sewer to saviour: targeting the lymphatic system to promote drug exposure and activity;Trevaskis;Nat. Rev. Drug Discov.,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Dynamics Simulation Study on the Mechanism of the inhibitory of N,N-dimethyl-3β- hydroxycholenamide (DMHCA) on 3β-hydroxysterol-Δ24-reductase(DHCR24);2023-11-22

2. Intra-articular Injection of a B Cell Depletion Antibody Enhances Local Exposure to the Joint-Draining Lymph Node in Mice with Collagen-Induced Arthritis;Molecular Pharmaceutics;2023-03-22

3. Obesity-associated mesenteric lymph leakage impairs the trafficking of lipids, lipophilic drugs and antigens from the intestine to mesenteric lymph nodes;European Journal of Pharmaceutics and Biopharmaceutics;2022-11

4. Intranodal delivery of modified docetaxel: Innovative therapeutic method to inhibit tumor cell growth in lymph nodes;Cancer Science;2022-02-14

5. Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity;Journal for ImmunoTherapy of Cancer;2021-07